Evidence map›Paper›PMID 35348223›Full record

ArticlePhotochemistry and photobiology2022

Flavonoid Nobiletin Exhibits Differential Effects on Cell Viability in Keratinocytes Exposed to UVA versus UVB Radiation.

William Cvammen, Michael G Kemp

Open access · hybridAbstract read
In one paragraph

Article in Photochemistry and photobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

William CvammenDepartment of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH.
Michael G KempDepartment of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH.ORCID 0000-0001-8203-0745
Wright State University · US

Funding

DNA damage response kinase signaling in non-replicating human cells and tissuesR01GM130583 · NIGMS · WRIGHT STATE UNIVERSITY · PI KEMP, MICHAEL GEORGE · 2019 to 2023
$1.5M
Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric SkinI01CX002241 · VA · DAYTON VA MEDICAL CENTER · PI Michael George Kemp · 2021 to 2026
–
CSRD VA I01 CX002241NIGMS NIH HHS GM130583NIGMS NIH HHS R01 GM130583
6 · The paper itself

Abstract

The polymethoxylated flavonoid nobiletin has been shown to suppress inflammatory responses to UVB radiation and to enhance circadian rhythms. Because expression of the core nucleotide excision repair (NER) factor XPA and the rate of removal of UV photoproducts from DNA are regulated by the circadian clock, we investigated whether the beneficial effects of nobiletin in UVB-exposed cells could be due in part to enhanced NER. Although nobiletin limited UVB-irradiated human keratinocytes from undergoing cell death, we found that this enhanced survival was not associated with increased NER or XPA expression. Instead, nobiletin reduced initial UV photoproduct formation and promoted a G1 cell cycle arrest. We then examined the implications of this findings for exposures to solar radiation through use of a solar simulated light (SSL) source that contains primarily UVA radiation. In striking contrast to the results obtained with UVB radiation, nobiletin instead sensitized keratinocytes to both the SSL and a more defined UVA radiation source. This enhanced cell death was correlated with a photochemical change in nobiletin absorption spectrum and the production of reactive oxygen species. We conclude that nobiletin is unlikely to be a useful compound for protecting keratinocytes against the harmful effects of solar UV radiation.

Indexed as

FlavonoidsUltraviolet RaysCell SurvivalFlavonesHumansKeratinocytesFlavonesFlavonoidsnobiletin

Identifiers

PMID35348223
PMCPMC9790495
OpenAlexW4225996894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.